Market Overview

Source Familiar with Matter Attributes Downside in Global Blood Therapeutics to Investor Concern Co. May Have Needed to Move Timeline of Drug Impact for Primary Endpoint on GBT440 from ~1 Month to ~6 Months

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: News Rumors FDA Market-Moving Exclusives Movers

 

Related Articles (GBT)

Anavex Life Sciences Joins The Club Of Stocks Moving Higher On News Of Alzheimer's Research

Next Summer, An Alternative For Detroit Baseball Fans